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The cultural characteristics of a bacillus capable of decomposing  the 
capsular polysaccharide of Type III Pneumococcus were described in 
the preceding paper (1).  The decomposition of the specific carbohy- 
drate was shown to be due to the action of an intracellular enzyme 
which  may  be  extracted  in  active  form  from  the  bacilli.  It  was 
pointed out that the enzyme acts only on the capsular polysaccharide 
of Type III  pneumococci and  does not affect the specific carbohy- 
drates  of certain other encapsulated bacteria.  In  this  respect,  the 
enzyme exhibits a selective action which is as unique in its specificity 
as is the serological reaction between the capsular polysaccharide and 
homologous antibody.  Furthermore, it was shown that the breaking 
down of the complex sugar by the enzyme is accompanied by a loss of 
the serological spedficity of the carbohydrate.  This form of decom- 
position by a biological agent represents a splitting which is less drastic 
than that  accomplished by chemical hydrolysis with acid and heat. 
The fact that the breaking down of the sugar molecule is, in each in- 
stance, accompanied by the loss of its immunological specificity fur- 
nishes convincing evidence that the capsular polysaccharide itself is 
the  substance  responsible  for  the  type  specificity of  pneumococci. 
The  observations recorded in  the preceding paper  concerned the 
action of the  enzyme on  the chemically purified polysaccharide re- 
moved and separate from the bacterial cells.  In its native state the 
capsular substance forms a  morphological structure which conditions 
the antigenic and serological reactilons of the cell as a whole, as well as 
its power to invade and multiply in the animal body.  It was of spe- 
cial interest, therefore,  to ascertain what effect this specific enzyme 
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would have upon  the  encapsulated  cells growing in vitro and in vivo; 
whether in a medium containing the active enzyme Type III pneumo- 
cocci  would  fail  to  grow,  or  would  grow  merely  deprived  of  their 
capsules; whether in the body of a  susceptible animal the administra- 
tion of the enzyme would in any way modify the course of experimental 
infection with virulent Type III pneumococci.  It is with  these  two 
questions  that  the  present  paper  deals. 
Before  discussing  the  experimental  restflts  to  be  reported  in  this 
paper, it may be well at this point to mention briefly the observations 
of other  investigators  who  have  attempted  to  modify or  inhibit  the 
activity of bacteria by the  use of certain  enzymes. 
Reference has  already been made in previous  papers  (1-3),  to  the  work of 
Toenniessen (4) who isolated in the form of galactan a gum-like material from an 
encapsulated strain of Friedlgnder's bacillus.  Of special interest in this regard is 
his observation on the utilization of this capsular substance by Bacillus vutgatus, 
when both organisms were grown together in symbiosis.  Under these conditions he 
observed that  the Friedl~nder  bacilli progressively lost  their  capsules,  although 
the viability of the decapsulated forms was in no way impaired.  This investigator 
attached no immunological significance  to the capsular carbohydrate, nor did he 
attempt  to  apply the  principle  involved in  this  symbiotic relationship  to  the 
problems of experimental infection.  Rather, Toenniessen regarded the substance 
of the capsule as a reserve food stuff, similar to starch in plants and glycogen in 
animals.  From this viewpoint, however, he emphasized the significance  of the 
capsule as a physiologically  important part of the bacterial cell and showed  that 
it may be decomposed by an unrelated species of microorganism. 
In 1910 Vaudremer (5)  pointed out  that  tuberculin,  when added  to filtered 
extracts of Aspergillusfumigatus, loses in great part its activity.  This decomposi- 
tion he attributed to the presence of various enzymes in the unheated extracts. 
He also showed that tubercle bacilli were modified by maceration in extracts of the 
fungus, and that under these conditions  they became granular and less acid-fast. 
The injection of the bacilli,  altered by growth in the fungus extracts, served to 
stimulate in animals an increased resistance to subsequent infection with virulent 
tubercle  bacilli.  Filtered  extracts  of  the  Aspergillus  alone  were  used  in  the 
treatment of guinea pigs previously infected with tubercle bacilli.  In these in- 
stances, the progress of the disease  was often much retarded and the life of the 
treated animals prolonged.  When Vaudremer had shown that unheated extracts 
of Aspergillus fumigatus  were able  to destroy tuberculin,  to diminish  the  acid 
resistance of tubercle bacilli,  and to retard infection in experimental animals, he 
applied the same methods to the treatment of tuberculosis in man. 
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culture of an unidentified mold was also observed by Machado (6) who traced this 
action to the activity of the fungus enzymes. 
The suggestion that the lipoid substances of tubercle and lepra bacilli may be 
acted upon by the esterases of  the tissues is found in the observations of  Citron 
and Reichen, Peritz and others (7), who have expressed the view that an increased 
content of these enzymes in the serum of patients is associated with an increased 
resistance to  infection.  The  relative resistance of  the skin  to  tuberculosis, as 
Porter pointed out, may possibly be related to the presence of the tissue lipase, 
although as Sexsmith and Petersen (8) suggest this resistance cannot be due wholly 
to the activity of this ferment since lepra bacilli, also rich in lipoids, invade the 
skin.  The observation by Robinovitch, Stiles, and Payne (9) that tuberculosis of 
the pancreas is relatively uncommon in tuberculous animals led these workers to 
attempt  to  influence the disease in experimentally infected guinea pigs by the 
injection of pancreatic extracts containing active lipase. 
The active principle, pyocyanase, present in autolysed cultures of B. pyocyaneus 
was found by Emmerich and his associates (10) to bring about rapid dissolution of 
many different species of living bacteria.  They considered the active agent to be 
an enzyme belonging to the class of nucleases.  Active preparations of pyocyanase 
were used in the treatment of animals experimentally infected with anthrax bacilli. 
The  protection  afforded  by  pyocyanase was  attributed to the direct action of 
the enzyme on the infecting bacilli. 
EXPER~~.NTAL 
C~ture.--¥oung,  plain  broth cultures  of a strain  of Type III Pneumococcus 
were used in the following  experiments.  The virulence  of the strain,  maintained 
by repeated mouse passage, was such that 0.00000001  cc. of culture injected intra- 
peHtoneally into white mice caused death within 36 to 72 hours.  The dilutions 
of the culture were made in broth in such manner that the infecting dose was always 
contained in a constant volume of 0.5 cc. 
Enzyme.--Ffltered solutions of the enzyme extracted from the SIII  bacillus 
were prepared as described in the preceding paper. 
Protection Tests.--White mice, 18 to 20 gm. in weight, served as test animals. 
All injections were made intraperitoneally and the technique commonly used in 
protection tests with antipneumococcus serum was employed.  Unless otherwise 
stated,  the  infecting organisms  and  enzyme  were  injected simultaneously.  In 
all instances the virulence of the culture was controlled by injecting normal mice 
with minimal amounts of the culture alone as shown in the protocols. 
I.  Action  of the  Enzyme  on  Encapsulated  Type  III  Pneumococci  in 
Vitro 
Reference has already been made to the observations of Toenniessen 
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these  organisms  are  grown  in  symbiosis with B.  vulgatus.  Similar 
relationships have been found to  exist in  the case of the symbiotic 
growth of an encapsulated strain of Type III Pneumococcus together 
with the enzyme-producing bacillus.  The specific enzyme elaborated 
by the bacilli brings about the decomposition of the capsular poly- 
saccharide formed by the Pneumococcus.  In symbiotic cultures of 
these  two  organisms,  the pneumococci lose  their  agglutinability in 
type-specific serum, and the soluble specific substance can no longer be 
demonstrated free in the culture fluid.  Obviously these results are 
conditioned by certain variable factors, such as  the  relationship be- 
tween the rate of decomposition and the rate of production of capsular 
substance, and the maintenance of cultural conditions suitable for the 
physiological activity of both species of microorganisms.  However, 
there is no difficulty in demonstrating the reaction when, instead of the 
living bacilli, a sterile extract of the enzyme itself is added in suitable 
concentration to  the  culture medium.  Under these  conditions the 
decomposition of the capsular polysaccharide by the enzyme can be 
demonstrated during growth of the pneumococci, by  failure of the 
culture to react specifically when added to Type III antipneumococcus 
serum. 
Experiments of this nature reveal the fact that the enzyme by itself 
is  neither  bactericidal  nor  bacteriolytic;  that  by  decomposing the 
specific  carbohydrate,  the  enzyme merely deprives  the  bacteria  of 
their capsules without impairing the viability of the cells.  It is also 
evident that the action of the enzyme does not result in a loss of the 
function of  elaborating  the  capsular  substance,  since  organisms so 
treated regain their capsule and form the specific polysaccharide when 
transferred to a medium free of the enzyme. 
The experiments reported in the preceding paper (1) showed that an 
enzyme  derived  from  an  unrelated  species  of  microorganisms acts 
upon the Type III  capsular polysaccharide of Pneumococcus when 
this substance, separated from the bacterial cells, is used as the specific 
substrate.  The experiments just described afford evidence that  the 
enzyme also  brings  about  the  decomposition of this  same  capsular 
material in the native form in which it exists as a  structural part of 
the living organism.  Since it has been shown that the enzyme has a 
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vitro,  the  question  naturally  arose,  whether  it would  exert  a  simUar 
action on the encapsulated forms growing in the animal body; to seek 
the  answer  to  this question  the  following experiments were  designed. 
II.  The Action of the Enzyme on Encapsulated  Type IH  Pneumococci 
in Vivo 
Specificity of the Action of Enzyme in Mice.--To  determine whether 
the enzyme would protect mice against infection, and to what  extent 
the  specificity exhibited by  the  enzyme in vitro  would be reflacted in 
TABLE  I 
Specificity  of  the  Protective Action of  Enzyme 
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D  =  death of animal; the numeral indicates the number of hours before death, 
or the time at which the animal was found dead. 
--  =  not done. 
its action in animals, three separate groups of mice were infected with 
Pneumococcus Types I, II, and III, each animal receiving at the same 
time  a  constant  amount  of  the  Type  III  specific  enzyme.  The 
experiment was carried out as follows: 
The technique of the protection test was the same as that already described. 
Three mice were injected intraperitoneally with 10 -4, 10 4, and 10-4 cc. of a broth 
culture of Type I Pneumococcus; three other mice received the same amounts of a 
culture of Type II; six mice were given much larger doses of a culture of Type III 
pneumococci ranging in amounts from 10 -1 to 10 -6 cc.  Simultaneously with the 
bacteria each mouse of all three groups received 0.5 cc. of the same preparation of 78  ENZYME  AGAINST  TYPE  III  PNEUMOCOCCUS 
enzyme (Lot 4-a).  The virulence of the three types of pneumococci was controlled 
in each instance by the infection of normal mice with 10 -5, 10  -8, and 10 -7 cc. of 
the respective culture alone. 
The  results of this experiment are  recorded in Table  I.  The evi- 
dence clearly shows that the enzyme afforded mice protection against 
1 million times the fatal dose of a  virulent culture of Type III Pneu- 
mococcus.  It is further apparent that the protective action is type- 
specific,  since  mice  receiving  the  same  enzyme  but  infected  with 
amounts as small as 0.000001  cc. of a  culture of a  heterologous type 
promptly succumbed  to  infection.  Just as in  the test tube,  the en- 
zyme acts only on the Type III polysaccharide, so in the animal body 
it  is  effective only against  infection with  Type  III  Pneumococcus. 
Heat Inactivation of the Enzyme.--Experiments  previously reported 
(1) showed that the activity of the enzyme, as measured by the decom- 
position  of  the  free  carbohydrate,  was  destroyed  by  exposure  to  a 
temperature  of 60°C.  for 10 minutes.  In  the following experiment, 
an  active  preparation  of the  enzyme was  heated,  at  a  temperature 
known to destroy completely its action in the test tube,  in order to 
determine  the  effect of heat  upon  the  protective  power  of  enzyme 
in mice. 
5 cc. of enzyme preparation (Lot 4-a) were heated in a water bath at 70°C. for 
10 minutes.  Each of three mice was injected intraperitoneally with 0.5 cc. of the 
heated enzyme together with a culture of Type III Pneumococcus in amounts of 
10  -4, 10 4, and 10 -8 cc. respectively.  Each of five other mice  received similar 
amounts of  the same preparation  of the unheated enzyme simultaneously  with 
an amount of the cultures  varying from 10 -1 to 10 4  cc., respectively.  Three 
mice infected with culture alone  in doses of 10  -5, 10 -6, 10 -7 cc. were  used as 
virulence controls. 
The  results of this  experiment  show  that  the  active  principle  re- 
sponsible for the protection of mice against infection is destroyed by 
exposure to 70°C. for 10 minutes.  Mice receiving the heated enzyme 
succumbed to infection with the gmallest dose of culture used, 0.000001 
cc.  On  the other hand, mice injected with an equal amount of the 
same enzyme unheated  survived as much as 0.1 cc. of the same culture 
of which 0.0000001  cc. alone proved fatal for the untreated controls. 
The inactivation by heat of the protective power of the enzyme in the 
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temperatures  of 60°C,  or higher.  The  fact  that  heat  destroys  the 
activity of the enzyme both in vitro and in vivo, supports the assump- 
tion  that  the  same  principle  is  involved in  the  mechanism  of both 
reactions. 
Relation between the Concentration  and Protective A ction of Enzyme.-- 
Repeated tests have demonstrated that within the limits of the reac- 
tion capacity of the mouse, the protective action of the enzyme is a 
function of the concentration of the active principle in any given prep- 
aration.  It is also apparent that the protection afforded by different 
TABLE  II 
Inactivation of Enzyme by Heat 















Heated at 70°C.  10 rain. 
D  34 
D  72 
D  72 
No enzyme 
Virulence control 
D  34 
D  34 
D  72 
D  = death of animal; the numeral indicates the number of hours before death. 
--  =  not done. 
* The inoculum at this dilution of culture (10  -~ cc.) yielded 13 colonies  on growth 
in blood agar. 
preparations  of the enzyme bears a  relation  to their  capacity to de- 
compose  a  known  quantity  of  the  capsular  polysaccharide  in  vitro. 
The  comparative  protective  action  in mice  of two  separate  prep- 
arations, oneof which was much less active in vitro is shown in Table 
III. 
From Table III it is evident that  Preparation  3, which was much 
less active than Preparation 4-a in decomposing the polysaccharide in 
the test tube, is also the less effective in the animal body.  Although 
the results obtained by the  two methods of titration  are not wholly 
comparable, they indicate the existence of a correlation between the in 
vitro and in vivo activity of the enzyme.  The comparison of these two 80  ENZYME  AGAINST  TYPE  III PNE~OCOCCUS 
different  preparations  also  suggests  that  the  concentration  of  the 
enzyme in Preparation 3 is close to the minimum threshold value below 
which the enzyme ceases to function in protecting against even mini- 
mal infecting doses.  From this and other similar experiments, the 
impression is gained that to be effective in animal protection, the con- 
centration of enzyme in the body must be in excess so that the rate of 
decomposition is greater than the rate of production of the capsular 
substance by the living bacteria.  The evidence also indicates that the 
greater the activity of the enzyme in vitro the greater is its protective 
TABLE  III 
Protective Action of Enzyme against Infection  wltk Pneumococcus Type III 
Difference in protection titre of two preparations of enzyme which show marked 
differences  in their activity in vitro. 

























D  34 
D  34 
D  72 
S  =  survival of animal. 
D  -- death of animal; the numeral indicates the number of hours before death. 
--  =  not done. 
action in mice.  Both of these deductions, however, suffer the limita- 
tions imposed by the variations which occur in the cellular response of 
the host, as will be pointed out later in discussing the importance of 
phagocytosis in the protective reaction. 
Titration of Protective  Action.--The concentration of enzyme in any 
given preparation as measured by the protection test in mice may be 
ascertained in two ways; (1) by determining the protective action of 
varying amounts of enzyme against a  fixed quantity of culture, and 
(2) by determining the maximum amount of culture against which a 
constant quantity of the enzyme will protect.  The results of experi- OSWALD  T.  AVERY  AND  REN~  DUBOS  81 
ments of this nature are given in Tables IV and V.  Although in the 
present instance both methods of titration were not carried out on the 
same preparation, the examples given illustrate the general principle. 
Table IV shows that 0.1  cc. of enzyme preparation protected mice 
against 0.01 cc. of a virulent culture, an amount 1 million times greater 
than the minimal dose fatal for the normal controls. 
TABLE  IV 
Titration of Protective Action of Enzyme against Infection witk Pneumococcus 
Type lit 
1. Varying  amounts of enzyme and constant amount of culture. 



























D  45 
D  35 
D  46 
S ffi survival of animal.  Observation period 10 days. 
D  ffi death of animal; the numeral indicates the number of hours before death 
of animal. 
* Inoculum of this amount of culture (10 -~ cc.) yielded 30 colonies  in blood agar. 
t Inoculum of this amount of culture (10 -8 cc.) yielded 1 colony in blood agar. 
The results presented in Table V illustrate the maximum amount of 
culture  against which  1  cc.  of  enzyme preparation  (4-a)  protected 
mice.  Under the experimental conditions, this particular preparation 
protected against infection with 0.2  cc.  of culture, an amount which 
represents 2 million fatal doses.  Death was delayed in mice infected 
with 0.3 and 0.4 cc. of culture, the animals surviving as long as 4 days. 
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upper limit against which a  single dose of the enzyme fails to protect. 
Whether repeated injections of enzyme during the  course of the in- 
fection, or whether the perfecting of methods for concentrating and 
purifying the enzyme will enhance its protective action, cannot now be 
stated.  Moreover the  maintenance  of an  effective concentration of 
enzyme in the body during the course of infection appears necessary to 
achieve  the  maximum  of  protection. 
In  order  to  ascertain  how  long  the  enzyme  remains  active  after 
injection into normal mice, the following experiment was carried out. 
TABLE V 
Titration  of Protective Action  of Enzyme,  against Infection  with Pneumococcus 
Type III 
2.  Constant amount of enzyme and varying amounts of culture. 
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D  -- death of animal; numeral indicates number of hours before death. 
S  ffi survival of animal. 
Mice were injected intraperitoneally with 1 ec. of a sterile solution of enzyme. 
At intervals thereafter varying from 20 to 43 hours, the mice were infected by 
the intraperitoneal injection of varying amounts of a virulent culture of Type III 
Pneumococcus. 
The results given in Tables VI and VII show that there is a  gradual 
diminution in the protective action of the enzyme after its injection 
into  the animal  body.  To determine more accurately the length  of 
time during which the enzyme remains active in normal animals will 
require further detailed study.  From the evidence available at pres- 
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TABLE  VI 
Protective Action of Enzyme against Infection with Pneumococcus Type III 
Action of enzyme given 24 hours before and simultaneously with the  infecting 
dose of culture. 
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Virulence  controls 
D  45 
D  35 
D  45 
D  =  death of animal; the numeral indicates the number of hours before death. 
S  ffi survival of animal--observation  period 10 days. 
=  not done. 
TABLE  VII 
Protective Action  of Enzyme  Given before Infection  with Pneumococcus Type III 











Enzyme  (Lot 6) 1  cc. 








Enzyme (Lot 4-a) 1  cc. given 
24 hrs. before 
infection 






43 hrs. before 
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D  48 
S 
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D  8 days 
S 
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S  -- survival of animal. 
D  =  death of animal; the numeral indicates the number of hours before death. 
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animal several days after the administration of a  single dose of the 
enzyme (Table VII) may be attributable to the loss or inactivation of 
the active agent during the course of the infection, thereby allowing a 
few organisms to escape and reestablish themselves in the absence of an 
effective concentration of the protective principle. 
Curative Action of the Enzyme in Mice.--The preceding experiments 
were  designed to  demonstrate  the  protective  action of  the  enzyme 
when administered simultaneously with the infecting microorganisms. 
In a  few experiments the enzyme was given several hours before the 
bacteria were injected, in order to ascertain the duration of the activity 
of enzyme in  the  animal body.  The  degree  of protection  afforded 
under these circumstances is noteworthy, when the susceptibility of 
mice to pneumococcus infection, and the virulence of the strain em- 
ployed  are  taken  into  consideration.  It  seemed  of  even  greater 
interest, however, to determine whether the enzyme would have any 
effect when injected into mice that had been previously infected with a 
fatal  dose  of  culture.  The  following experiment  illustrates  the  so 
called curative action of the enzyme in the presence of an infection 
already established at the  time of treatment. 
Nine normal mice were infected with 10  -6 cc. of broth culture of a virulent 
strain of Pneumococcus  Type III.  12 hours later three of these animals  were  given 
an intraperitoneal injection of 1 cc. of enzyme (Preparation 4-a).  Three other 
mice of the infected  group were treated with the same amount of enzyme 18 hours 
after the infecting organisms had been given.  The remaining three mice received 
no enzyme and served as untreated controls.  As further controls of virulence 
two normal mice were injected with the culture alone in amounts of 10  -7 and 10  -8 
cc.  respectively.  To  estimate  the  number of  organisms, these inocula were 
plated in blood agar and the number of colonies developing were counted.  10  -v 
cc.  of culture yielded twenty-five colonies in the poured plates, and  10  -8  cc., 
three colonies. 
The results of this experiment on the curative action of the enzyme 
(Table VIII) show that mice receiving a single injection of the enzyme 
18 hours after the onset of infection, recovered, whereas the untreated 
controls all died.  Under the experimental conditions, the survival of 
the  treated  animals  represents  recovery  from an  infecting dose  of 
culture 100  times greater than that fatal for untreated mice.  While 
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cates  that  the  enzyme is  effective when  administered early  in  the 
course of an infection which otherwise invariably proves fatal.  From 
other experiments, evidence has been gained that the administration 
of the enzyme several hours after infection with larger amounts of 
culture may favorably influence the course of the infection in mice. 
Mechanism  of the Protective Action.--It  was thought possible that 
some idea of the mechanism involved in the protective action of the 
enzyme in infected mice might be gained by following the course of 
the bacteremia by means of blood cultures, and by a  study of the 
TABLE  VIII 
Curative Action of Enzyme in Mice Infected  witk Pneumococcus Type III 
Pneumococcus Type III 







Enzyme 1 cc. (Lot 4-~) given 








D  =  death of animal; the numeral indicates the number of hours before death. 
S  -- survival of animal. 
* -- Inoculum of this dilution of culture (10 -~ cc.) gave 25 colonies in blood agar. 
t  Inoculum of this dilution of culture (10 -s cc.) gave 3 colonies in blood agar. 
cellular reactions in the peritoneal exudates of treated and untreated 
animals.  A  typical experiment follows: 
Twelve mice were injected intraperitoneally with 10  -2 cc. of a culture of Pneu- 
mococcus Type III, the virulence of which was such that 10  -s cc. caused death in 
from 36 to 72 hours.  Six of the mice also received at the time of infection 0.5 cc. 
of an active preparation of the enzyme.  The other six infected animals served 
as untreated controls.  At hourly intervals following infection, one mouse of each 
group was sacrificed and autopsied.  Cultures of the heart's blood were made in 
broth and on blood agar plates.  Films of the peritoneal exudates were stained by 
the Gram method, and examined to compare differences in the morphology of the 
organism  and  in  the  occurrence of phagacytosis  in  the  treated  and  untreated 
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The results of blood cultures taken during the course of the infection 
show that the enzyme has a distinct effect in checking the bacteremia 
which invariably occurs in  infected mice.  In both  the treated and 
untreated animals pneumococci are present in the blood stream within 
the 1st hour following infection.  However, the subsequent course of 
events, with reference to the persistence of bacteremia, differs in the 
two series o'f animals.  For, while the bacteria progressively increase 
in the blood of the control mice until death, they invariably diminish 
in numbers in the circulation of the treated animals until by the 4th 
or 5th hour they can no longer be  demonstrated by culture.  The 
sterilization of the blood under these conditions is objective evidence of 
the protective action of the enzyme. 
The fate of the pneumococci under the influence of the enzyme is 
strikingly revealed by microscopic  study of  the  peritoneal  exudate 
during the course of the infection.  Without giving in detail the re- 
sults of the serial examinations at hourly intervals,  the progress of 
events is shown  in the accompanying photomicrographs which illus- 
trate the differences in the cellular reactions of treated and untreated 
mice 2 and 4 hours after the injection of 1 million fatal doses of Pneu- 
mococcus Type III.  Two hours after infection the peritoneal exudate 
of the untreated control mouse (Fig.  1)  shows numerous well encap- 
sulated cocci free in the fluid.  In contrast to this, the pneumococci in 
the exudate of the enzyme-treated animal at this time  (Fig.  2)  are 
devoid of capsules  and only the naked bacteria are visible,  many of 
which are already engulfed by the polynuclear leucocytes.  At the end 
of 4 hours, the number of encapsulated pneumococci have increased 
in the peritoneum of the untreated control (Fig.  3),  there is no evi- 
dence of phagocytosis,  and  cultures of  the  heart  blood  indicate  a 
progressively increasing bacteremia.  In the treated mouse at the end 
of 4 hours (Fig. 4) only an occasional  unencapsulated organism is seen 
outside the accumulated leucocytes and frequently at this time and 
almost invariably by the 5th hour, pneumococci are no longer demon- 
strable by blood cultures.  These findings have been repeatedly con- 
firmed in a series of similar experiments and they support the view that 
the protective action of the enzyme  lies in its capacity to decompose the 
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DISCUSSION 
The present study emphasizes the importance of the capsule in the 
biological reactions of the pneumococcus.  It  is, indeed, a  significant 
fact, that no matter whether one regards tMs organism from the view- 
point  of  type  specificity,  antigenicity,  or  its  capacity  to  undergo 
variation,  or whether, as in the present instance, one considers the 
pneumococcus with  reference to its virulence and fate in the animal 
body, the one dominant factor influencing all these phenomena is the 
function of the cell to elaborate the specific  capsular polysaccharide. 
These relationships, however, are  not to  be  interpreted as meaning 
that  virulence  is  dependent merely  upon  differences  in  the  struc- 
tural morphology of the bacterial ceil.  For it is a  common observa- 
tion  that an  encapsulated strain  of Pneumococcus may be virulent 
for one species and not for another.  However, it is equally true that 
the function of elaborating the specific capsular polysaccharide is most 
highly developed in pneumococci that are best adapted to growth in 
the  animal  body.  From  this  point of view,  virulence and  capsule 
formation, although not causally related, are at ]east intimately asso- 
ciated.  When  the  function  of  forming  the  capsular  substance  is 
suppressed or inhibited, as in the case of the R variants, or when, as in 
the present instance, although this function is unimpaired the capsule 
itself is destroyed by an enzyme, the naked bacteria are thereby ex- 
posed directly to attack by the phagocytes of the host. 
In this sense,  the action of the enzyme may be  said to  result in 
preparing the encapsulated bacferia for phagocytosis; not, as in the 
case  of antibodies,  by  specific sensitization,  but  by  the process of 
decapsulation.  In the former instance, the reaction is an immuno- 
logical one, whereby the capsular material is altered by union with the 
type-specific antibody; in the latter case, the reaction is a chemical one 
in which the capsular polysaccharide is actually decomposed by the 
enzyme.  Although the mode of action of both these specific agents 
is different in each instance, the end result, so far as the fate of the 
microorganism is concerned, is the same in both cases. 
It is of interest that although neither the enzyme nor the specific 
antibody is by itself bactericidal or bacteriolytic, yet each by reacting 
specifically with the capsular substance exposes the virulent organisms 
to the phagocytic action of the body tissues.  The enzyme, like the 88  ENZYME  AGAINST TYPE III PIWE~OCOCCUS 
specific  antibody, serves merely to  initiate  the  protective reaction, 
the  completion of which is  ultimately dependent for  its  successful 
issue upon the effective cellular response of the host. 
The present study also suggests that the capsule--long recognized 
as a defense mechanism on the part of virulent bacteria--is a decisive 
factor in determining the fate of pneumococci in the animal body, and 
that this structure is vulnerable to attack by specific agents other than 
antibodies. 
SUMMARY 
The bacterial enzyme which decomposes the purified capsular poly- 
saceharide of Type III Pneumococcus in vitro  also destroys the cap- 
sules of the living organisms growing in media and in the animal body. 
Potent preparations of this same enzyme protect mice against in- 
fection with virulent Type III Pneumococcus.  The protective action 
is  type-specific. 
The protective activity of the specific enzyme is destroyed by heat 
(70°C. for 10 minutes). 
The enzyme remains in an  effective concentration 24  to 48 hours 
after its injection into normal mice. 
The enzyme has been found to exert a  favorable influence on the 
outcome of an infection already established at the time of treatment. 
A definite relationship has been found to exist between the activity 
of the enzyme in vitro  and its protective power in the animal body. 
The mechanism of the protective action is discussed with special 
reference to the relation between the decapsulation of the bacteria by 
the enzyme and the phagocytic response of the host. 
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EXPLANATION OF PLATE 4 
FxG. 1.  Photomicrograph of a stained preparation of the peritoneal exudate of 
a mouse 2 hours after the intraperitoneal injection of 0.01 cc. of a virulent culture 
of Type III Pneumococcus.  The  bacteria  show well  defined  capsules  and  no 
evidence  of phagocytosis is  seen.  Many  polymorphonuclear and  a  moderate 
number of mononuclear leucocytes are present.  Gram stain,  X 1000. 
FIG.  2.  Photomicrograph of a  corresponding  preparation of the exudate of a 
mouse 2 hours after receiving the same amount of culture together with 0.5 cc. of a 
preparation of the specific enzyme.  The bacteria are devoid of capsules.  Poly- 
morphonuclear leucocytes predominate and phagocytosis is evident.  Gram stain, 
X 1000. 
F~G. 3.  Photomicrograph of a stained film of the peritoneal exudate of a mouse 
4 hours after injection with 0.01 ec. of culture alone.  The bacteria are increased 
in  number,  encapsulated,  and  extracellular.  The  cellular  elements  are  poly- 
morphonuclear  and  mononuclear  leucocytes  in  about  equal  numbers.  Gram 
stain,  X 1000. 
FIG. 4.  Photomicrograph of a  corresponding  preparation of the exudate of a 
mouse 4 hours after receiving the same amount of culture together with 0.5 cc. of a 
preparation of the specific enzyme.  Marked phagocytosis has occurred and only 
an occasional organism is seen outside the accumulated leucocytes, nearly all of 
which are of the polymorphonuclear type.  Gram stain,  X1000. 
Differences in the density of the backgrounds of the four figures are due to the 
use of color screens in the photographic reproductions.  This technique, however, 
alters none of the essential details observed in the original microscopic preparations. THE JOURNAL  OF  EXPERIMENTAL  MEDICINE VOL.  54  PLATE 4 
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